Algo version: 0.98b
Bristol-Myers Squibb Co is listed at the XETRA Exchange
Bristol-Myers Squibb Co [BRM.DE]
XETRA Sector: Pharmaceuticals Industry:Drug Manufacturers—General

Is Bristol-Myers Squibb Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Bristol-Myers Squibb Co pays dividends. Last time was Thursday 1st of August 2024 where the investors holding the stock on Friday 5th of July 2024 were paid €0.55366 per share. Over the last 99 times between 1999 and 2024, Bristol-Myers Squibb Co has paid €35.09366 with an average of €0.35 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Bristol-Myers Squibb Co 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €43.13, you would have made a profit of €1.090 per share or 2.53%

No, the average daily trading liquidity for Bristol-Myers Squibb Co is €4 279 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Bristol-Myers Squibb Co has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Bristol-Myers Squibb Co to be high [0.75 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.